...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Questrade

Of the 3k today, I only got 1k. Something weird going on, in my opinion. 

Share
New Message
Please login to post a reply